[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361834-105":59,"doc-detail-361834-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","malignancy-in-systemic-sclerosis-a-multicenter-retrospective-study","Malignancy in Systemic Sclerosis - A Multicenter Retrospective Study","","Systemic sclerosis (SSc) is linked to elevated malignancy risk, and improvements in disease management may alter tumor occurrence patterns. A multicenter Hungarian study retrospectively analyzed 541 SSc patients from 2018–2024 to quantify malignancy prevalence and identify associated risk factors, comparing findings with prior local and international data. Eighty-five patients developed 96 tumors. Skin cancer predominated, with two temporal peaks around diagnosis and 10 years later. Anti-RNAPIII, ATA, diffuse cutaneous disease, female sex, smoking, and older age increased risk, while pregnancy did not protect against breast cancer. Malignancy worsened mortality, and dermatologic screening is recommended for all SSc patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/malignancy-in-systemic-sclerosis-a-multicenter-retrospective-study/361834/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/malignancy-in-systemic-sclerosis-a-multicenter-retrospective-study/361834.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main objective in Hungarian systemic sclerosis patients?","Question",{"text":112,"@type":113},"To determine malignancy prevalence and its risk factors in the Hungarian SSc population, and to compare results with prior national and international findings.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cancers were most common and when did tumors tend to appear?",{"text":117,"@type":113},"Skin cancer was most common, followed by breast and lung cancer. Tumors clustered in two peaks: around SSc diagnosis and about 10 years later.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with higher malignancy risk and mortality?",{"text":121,"@type":113},"Anti-RNAPIII positivity, anti-topoisomerase I (ATA) positivity, female gender, diffuse cutaneous SSc, smoking, and older age were linked to higher risk. Cancer patients were older and had worse mortality than non-cancer patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361834,1790196777,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nMalignancy in Systemic Sclerosis: A Multicenter Retrospective Study  \nDóra Nemes-Tömöri 1, *, Dávid Kurszán Jász 2,†, Dóra Tari 3,†, Bernadett Bói 4, Ágnes Ágoston-Szabó 2, Gabriella Sz ˝ucs 3 and Gyöngyike Emese Majai 1  \nAcademic Editor: Bo-Ying Bao  \nReceived: 18 March 2025  \nRevised: 16 April 2025  \nAccepted: 17 April 2025  \nPublished: 19 April 2025  \nCitation: Nemes-Tömöri, D.; Jász, D.K.; Tari, D.; Bói, B.; Ágoston-Szabó,Á.; Sz ˝ucs, G.; Majai, G.E. Malignancy in Systemic Sclerosis: A Multicenter Retrospective Study. Biomedicines 2025, 13, 993. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biomedicines13040993  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Division of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, Móricz Zsigmond Road 22, 4032 Debrecen, Hungary; [mgyongyi@med.unideb.hu](mgyongyi@med.unideb.hu)  \n2 Department of Rheumatology and Immunology, Medical School, University of Pécs, Akác Street 1, 7632 Pécs, Hungary; [jasz.david@pte.hu](jasz.david@pte.hu) (D.K.J.); [szabo.agnes@pte.hu](szabo.agnes@pte.hu) (Á .Á .-S.)  \n3 Department of Rheumatology and Immunology, Faculty of Medicine, University of Debrecen, Móricz Zsigmond Road 22, 4032 Debrecen, Hungary; [tari.dora@med.unideb.hu](tari.dora@med.unideb.hu) (D.T.); [szucs.gabriella@med.unideb.hu](szucs.gabriella@med.unideb.hu) (G.S.)  \n4 Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Kassai Road 26, 4028 Debrecen, Hungary; [boi.bernadett@med.unideb.hu](boi.bernadett@med.unideb.hu)  \n* [Correspondence: nemes.tomori.dora@med.unideb.hu](Correspondence: nemes.tomori.dora@med.unideb.hu)[ ](Correspondence: nemes.tomori.dora@med.unideb.hu)† These authors contributed equally to this work.  \nAbstract: Background/Objectives: Systemic sclerosis (SSc) is associated with high malignancy risk. With improving SSc management, tumor risk could change, therefore re-evaluating the possibility of neoplasms is necessary. Our aim was to observe malignancy prevalence and its risk factors in the Hungarian SSc population, comparing them to our previous and international results. Methods: We retrospectively collected the data of SSc patients followed by and admitted to three Hungarian clinical centers between 2018 and 2024. The collected data included the characteristics of SSc and neoplasms, autoantibody positivities, immunosuppressive treatments, pregnancy and environmental factors. Results: Out of 541 patients, 85 had malignancy and, in total, 96 tumors were registered. Skin cancer was the most common (n = 24), followed by breast (n = 14) and lung cancer (n = 14) . Among skin cancers, almost one-third was melanoma. Tumors mostly appeared in two peaks: around the time of SSc diagnosis and 10 years later. The occurrence of anti-RNA Polymerase III (anti-RNAPIII) was significantly higher in cancerous patients. Tumor risk was higher with anti-RNAPIII (Odds Ratio (OR) 4.33, 95% Confidence Interval (95% CI) 1.08, 15.1) and anti-topoisomerase I (ATA) (OR 2.34, 95% CI 0.94, 5.84) positivity. Women and patients with diffuse cutaneous SSc (dcSSc) were more likely to have malignancy. Smoking (OR 1.27, 95% CI 0.53, 3.00) also raised the possibility of carcinogenesis. Cancerous patients were older (p-value = 0.003), and their mortality was worse compared to non-cancerous patients (Hazard Ratio (HR) 4.75, 95% CI 2.12, 10.62) . Pregnancy did not provide a protective effect against breast cancer. Conclusions: Malignancy significantly contributes to the increased mortality in SSc. Female gender, dcSSc, anti-RNAPIII positivity, smoking and older age represent a higher risk of t","cbCailf2eyVakSb6","https://ap.wps.com/l/cbCailf2eyVakSb6","pdf",4331054,16,"English","# Abstract\n# Introduction","[{\"question\":\"What was the study’s main objective in Hungarian systemic sclerosis patients?\",\"answer\":\"To determine malignancy prevalence and its risk factors in the Hungarian SSc population, and to compare results with prior national and international findings.\"},{\"question\":\"Which cancers were most common and when did tumors tend to appear?\",\"answer\":\"Skin cancer was most common, followed by breast and lung cancer. Tumors clustered in two peaks: around SSc diagnosis and about 10 years later.\"},{\"question\":\"Which factors were associated with higher malignancy risk and mortality?\",\"answer\":\"Anti-RNAPIII positivity, anti-topoisomerase I (ATA) positivity, female gender, diffuse cutaneous SSc, smoking, and older age were linked to higher risk. Cancer patients were older and had worse mortality than non-cancer patients.\"}]","Malignancy in Systemic Sclerosis - A Multicenter Retrospective Study | PDF",1790145725,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/913f164ec9f4d792e9afe73a46687605.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe79907956993784e277d3d14deed11c.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08414742fd8244a1728f5e2566956c6b.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3ca6a2a6c628cb2e99fd957b58c469d.webp",980,1385]